본문

  1. Home
8 Results:AA:N MIYA PP:ELSEVIER INC 0.140 sec.
RSS 
Multilingual
 Расширенный поиск
 Новый поиск книги прибытия
Selected Print Select Export to Excel
1
Human parathyroid hormone (1???34) accelerates the fracture healing process of woven to lamellar bone replacement and new cortical shell formation in rat femora
Human parathyroid hormone (1???34) accelerates the fracture healing process of woven to lamellar bone replacement and new cortical shell formation in rat femora
Komatsubara, S., | Elsevier Inc | 2005 ,
2
Intermittent administration of human parathyroid hormone enhances bone formation and union at the site of cancellous bone osteotomy in normal and ovariectomized rats.
Intermittent administration of human parathyroid hormone enhances bone formation and union at the site of cancellous bone osteotomy in normal and ovariectomized rats.
Koji Nozaka,, | Elsevier Inc | 2008 ,
3
Involvement of GCMB in the transcriptional regulation of the human parathyroid hormone gene in a parathyroid-derived cell line PT-r
Involvement of GCMB in the transcriptional regulation of the human parathyroid hormone gene in a parathyroid-derived cell line PT-r
Kawahara, M., | Elsevier Inc | 2010 ,
4
Vertebral fracture status and the World Health Organization risk factors for predicting osteoporotic fracture risk in Japan
Vertebral fracture status and the World Health Organization risk factors for predicting osteoporotic fracture risk in Japan
Fujiwara, S., | Elsevier Inc | 2011 ,
5
Effects of teriparatide on bone mineral density and bone turnover markers in Japanese subjects with osteoporosis at high risk of fracture in a 24-month clinical study: 12-Month, randomized, placebo-controlled, double-blind and 12-month open-label phases
Effects of teriparatide on bone mineral density and bone turnover markers in Japanese subjects with osteoporosis at high risk of fracture in a 24-month clinical study: 12-Month, randomized, placebo-controlled, double-blind and 12-month open-label phases
Miyauchi, A., | Elsevier Inc | 2010 ,
6
IGF-I secreted by osteoblasts acts as a potent chemotactic factor for osteoblasts
IGF-I secreted by osteoblasts acts as a potent chemotactic factor for osteoblasts
Nakasaki, M., | Elsevier Inc | 2008 ,
7
The Fracture and Immobilization Score (FRISC) for risk assessment of osteoporotic fracture and immobilization in postmenopausal women A joint analysis of the Nagano, Miyama, and Taiji Cohorts
The Fracture and Immobilization Score (FRISC) for risk assessment of osteoporotic fracture and immobilization in postmenopausal women A joint analysis of the Nagano, Miyama, and Taiji Cohorts
Tanaka, S., | Elsevier Inc | 2010 ,
8
Fibroblast growth factor 23 concentrations in healthy term infants during the early postpartum period
Fibroblast growth factor 23 concentrations in healthy term infants during the early postpartum period
Takaiwa, M., | Elsevier Inc | 2010 ,
처음1마지막